VULTUS AB (V06) - Cash Flow Conversion Efficiency
Based on the latest financial reports, VULTUS AB (V06) has a cash flow conversion efficiency ratio of -14.938x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€25.38 Million ≈ $29.67 Million USD) by net assets (€-1.70 Million ≈ $-1.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see V06 stock market capitalisation for the company's overall valuation and market capitalisation.
VULTUS AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how VULTUS AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View VULTUS AB share price for real-time trading data and today's change.
VULTUS AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VULTUS AB ranked by their cash flow conversion efficiency. Review V06 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Robin Energy Ltd.
NASDAQ:RBNE
|
0.056x |
|
Future Supply Chain Solutions Limited
NSE:FSC
|
0.108x |
|
Clasquin
PA:ALCLA
|
-0.099x |
|
Iofina plc
LSE:IOF
|
0.129x |
|
A Luzon Real Estate & Finance Ltd
TA:LZNR
|
-0.005x |
|
Shyam Telecom Limited
NSE:SHYAMTEL
|
0.000x |
|
Siwani Makmur Tbk
JK:SIMA
|
3.493x |
|
Yida China Holdings Ltd
STU:YC2
|
N/A |
Annual Cash Flow Conversion Efficiency for VULTUS AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of VULTUS AB from 2021 to 2025. Also see VULTUS AB total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €34.63 Million ≈ $40.48 Million |
€24.72 Million ≈ $28.90 Million |
0.714x | +181.79% |
| 2024-12-31 | €2.47 Million ≈ $2.89 Million |
€-2.16 Million ≈ $-2.52 Million |
-0.873x | +37.60% |
| 2023-12-31 | €5.20 Million ≈ $6.08 Million |
€-7.27 Million ≈ $-8.50 Million |
-1.399x | -82.31% |
| 2022-12-31 | €7.06 Million ≈ $8.26 Million |
€-5.42 Million ≈ $-6.34 Million |
-0.767x | -10.26% |
| 2021-12-31 | €3.53 Million ≈ $4.13 Million |
€-2.46 Million ≈ $-2.87 Million |
-0.696x | -- |
About VULTUS AB
C100 AB (publ) is public investment firm specializing in early stage and Emerging stage. The Firm prefers to invest in Technology and Life science Sector. The Firm Typically focuses on early-stage biotech platforms, emerging digital health technologies, transformative software solutions for the investments. C100 AB (publ) is based in stockholm, Sweden.